Free Trial

Tenax Therapeutics (TENX) Competitors

Tenax Therapeutics logo
$5.92 +0.16 (+2.69%)
Closing price 02:43 PM Eastern
Extended Trading
$5.88 -0.04 (-0.59%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TENX vs. HURA, IOBT, WHWK, OCX, VIRI, CRBP, ADAG, ENTX, ORMP, and JMAC

Should you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include TuHURA Biosciences (HURA), IO Biotech (IOBT), Whitehawk Therapeutics (WHWK), OncoCyte (OCX), Virios Therapeutics (VIRI), Corbus Pharmaceuticals (CRBP), Adagene (ADAG), Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), and Maxpro Capital Acquisition (JMAC). These companies are all part of the "pharmaceutical products" industry.

Tenax Therapeutics vs. Its Competitors

Tenax Therapeutics (NASDAQ:TENX) and TuHURA Biosciences (NASDAQ:HURA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Tenax Therapeutics has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, TuHURA Biosciences has a beta of 0.17, indicating that its share price is 83% less volatile than the S&P 500.

TuHURA Biosciences' return on equity of 291.69% beat Tenax Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Tenax TherapeuticsN/A -31.51% -30.35%
TuHURA Biosciences N/A 291.69%122.09%

In the previous week, TuHURA Biosciences had 4 more articles in the media than Tenax Therapeutics. MarketBeat recorded 4 mentions for TuHURA Biosciences and 0 mentions for Tenax Therapeutics. Tenax Therapeutics' average media sentiment score of 0.00 beat TuHURA Biosciences' score of -0.53 indicating that Tenax Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Tenax Therapeutics Neutral
TuHURA Biosciences Negative

Tenax Therapeutics currently has a consensus price target of $17.50, indicating a potential upside of 195.86%. TuHURA Biosciences has a consensus price target of $12.67, indicating a potential upside of 408.70%. Given TuHURA Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe TuHURA Biosciences is more favorable than Tenax Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenax Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
TuHURA Biosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40

1.7% of Tenax Therapeutics shares are owned by institutional investors. Comparatively, 0.6% of TuHURA Biosciences shares are owned by institutional investors. 3.1% of Tenax Therapeutics shares are owned by insiders. Comparatively, 0.2% of TuHURA Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenax TherapeuticsN/AN/A-$17.60M-$2.48-2.39
TuHURA BiosciencesN/AN/A-$21.68MN/AN/A

Summary

TuHURA Biosciences beats Tenax Therapeutics on 6 of the 11 factors compared between the two stocks.

Get Tenax Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TENX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TENX vs. The Competition

MetricTenax TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$23.90M$2.90B$5.51B$8.96B
Dividend YieldN/A2.44%5.25%4.02%
P/E Ratio-2.3921.0128.0520.15
Price / SalesN/A294.68438.14127.85
Price / CashN/A41.8337.0657.97
Price / Book0.227.868.125.62
Net Income-$17.60M-$54.95M$3.16B$248.50M
7 Day Performance3.05%6.24%4.40%5.54%
1 Month Performance0.94%5.70%4.09%7.52%
1 Year Performance85.42%8.08%34.53%22.06%

Tenax Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TENX
Tenax Therapeutics
1.2571 of 5 stars
$5.92
+2.7%
$17.50
+195.9%
+81.7%$23.90MN/A-2.399
HURA
TuHURA Biosciences
1.2124 of 5 stars
$2.23
+0.5%
$12.67
+468.0%
N/A$96.97MN/A0.00N/AGap Up
IOBT
IO Biotech
3.2598 of 5 stars
$1.39
-3.5%
$9.33
+571.5%
+22.9%$94.87MN/A-0.9330News Coverage
WHWK
Whitehawk Therapeutics
N/A$1.87
-3.1%
N/AN/A$90.92M$25.98M0.0040
OCX
OncoCyte
2.0071 of 5 stars
$3.18
+16.3%
$6.06
+90.9%
+5.8%$90.80M$3.84M-0.90120
VIRI
Virios Therapeutics
N/A$4.71
-1.3%
$5.00
+6.2%
+1,782.4%$90.71MN/A-17.445Gap Up
CRBP
Corbus Pharmaceuticals
3.8204 of 5 stars
$6.90
-6.8%
$50.88
+637.3%
-85.2%$90.55MN/A-1.6440
ADAG
Adagene
2.0015 of 5 stars
$1.95
+1.6%
$8.00
+310.3%
-33.0%$90.45M$100K0.00260News Coverage
ENTX
Entera Bio
2.2215 of 5 stars
$1.90
-4.0%
$10.00
+426.3%
+0.6%$89.99M$180K-7.3120News Coverage
Positive News
ORMP
Oramed Pharmaceuticals
0.2691 of 5 stars
$2.25
+4.7%
N/A-17.1%$87.83M$1.34M-5.1110Gap Up
JMAC
Maxpro Capital Acquisition
N/A$6.51
+1.5%
N/A+3,268.2%$87.42MN/A0.002,021

Related Companies and Tools


This page (NASDAQ:TENX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners